GWM
LMAT icon

Geneos Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Geneos Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-551
Closed -$45.8K – 2882
2025
Q2 		$45.8K Sell
551
-812
-60% -$67.9K ﹤0.01% 1619
2025
Q1 		$114K Buy
1,363
+1,204
+757% +$112K ﹤0.01% 1495
2024
Q4 		$14.7K Buy
159
+11
+7% +$1.06K ﹤0.01% 1879
2024
Q3 		$13.7K Buy
+148
New +$12.8K ﹤0.01% 1709

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's LMAT Position: Q3 2025 in Review

Geneos Wealth Management sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 551 shares — an estimated $45.8K sold.

Geneos Wealth Management first reported a position in LMAT in Q3 2024 and held it in 4 quarters. The position peaked at $114K in Q1 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Geneos Wealth Management reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 551 LeMaitre Vascular shares in Q3 2025, an estimated $45.8K.
  • Geneos Wealth Management first reported a position in LeMaitre Vascular in Q3 2024 and held it in 4 quarters.
  • Geneos Wealth Management's LeMaitre Vascular position peaked at $114K in Q1 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.